News
Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) ...
Viking Therapeutics became famous in the biotech world last year after announcing positive phase 2 results for VK2735, an ...
For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is expected at 16-24% growth. However, this forecast, 3% lower for revenue and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results